Page last updated: 2024-09-05

zm 241385 and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

zm 241385 has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies (zm 241385)	Trials (zm 241385)	Recent Studies (post-2010) (zm 241385)	Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)
401	3	124	640	13	233

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carroll, MA; Doumad, AB; Falck, JR; Li, J; Liclican, EL; Stier, CT; Wang, J	1

Other Studies

1 other study(ies) available for zm 241385 and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

Article	Year
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6 Topics: Adrenergic alpha-2 Receptor Antagonists; Amides; Animals; Blood Pressure; Drinking; Eicosanoids; Hydroxyeicosatetraenoic Acids; Hypertension, Renal; Male; Natriuresis; Oxidoreductases; Rats; Rats, Inbred Dahl; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary; Triazines; Triazoles	2009

Article

Year

Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.

Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6

Topics: Adrenergic alpha-2 Receptor Antagonists; Amides; Animals; Blood Pressure; Drinking; Eicosanoids; Hydroxyeicosatetraenoic Acids; Hypertension, Renal; Male; Natriuresis; Oxidoreductases; Rats; Rats, Inbred Dahl; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary; Triazines; Triazoles

2009